Washington, D.C.- Congresswoman Diana Harshbarger released the following statement on introducing the PBM Accountability Study Act of 2021. The bill calls for a study into ways to increase transparency of pharmacy benefit managers (PBMs), which are the middlemen who negotiate payments between health insurers, pharmacies, and drug companies.
Washington, D.C.- Congresswoman Diana Harshbarger released the following statement after her votes against Democrat-led bills that infringe upon law-abiding citizens’ Second Amendment Rights: H.R. 8, the Background Checks Act, and H.R. 1446, the Enhanced Background Checks Act of 2021.
Washington, D.C.- Congresswoman Diana Harshbarger released the following statement outlining her opposition to the Democrats’ partisan $1.9 trillion stimulus bill.
Kingsport, TN- Congresswoman Diana Harshbarger released the following statement regarding the critical infrastructure designation for the Neopharma pharmaceutical manufacturing facility located in Bristol, TN. The plant is the only domestic turn-key facility to allow for the full production of penicillin.
U.S. Capitol Building
Washington, D.C.- Congresswoman Diana Harshbarger released the following statement today regarding the partisan budget reconciliation proposal by President Biden and Congressional Democrats.
U.S. Capitol Building
Kingsport, TN- Congresswoman Diana Harshbarger released the following statement today regarding her selection to the House Committee on Education and Labor and the House Committee on Homeland Security.
Washington, DC- Today, Congresswoman Diana Harshbarger released the following statement after accepting an invitation to join the House Republican Whip Team.
U.S. Capitol Building
Washington, DC- Congresswoman Diana Harshbarger released the following statement regarding efforts to remove President Trump from office prior to the conclusion of his term.
Washington, D.C. - Congresswoman Diana Harshbarger made the following statement regarding the Electoral College certification:
